This report delivers comprehensive strategic intelligence on the world's leading Biotechnology companies. Amgen leads with revenues of approximately $34 billion. Gilead Sciences generates approximately $28 billion. Regeneron generates approximately $14 billion. Vertex Pharmaceuticals has achieved dominance in cystic fibrosis with margins exceeding 40%. Alnylam has commercialized five RNAi therapies. Genmab's antibody platform generated $3.72 billion in 2025. The industry is advancing on mRNA therapeutics, gene editing, bispecific antibodies, and AI-driven drug discovery simultaneously.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Companies Analyzed in This Report:
Alnylam Pharmaceuticals
Amgen
Biogen
BioNTech
CSL Behring
Genmab
Gilead Sciences
Moderna
Regeneron
Vertex Pharmaceuticals
The Analysis of Each Company Includes:
• Strategic Directions and Corporate Priorities
• Financial Performance and Revenue Breakdown
• SWOT Analysis
• Technological Know-How and Innovation Programs
• Latest Products and Services
• M&A, Partnerships and Alliances
• Marketing Tactics and Commercial Strategy
• Organization and Management Structure
Topics Covered
• Strategic Directions and Corporate Priorities
• Financial Performance and Revenue Breakdown
• SWOT Analysis
• Technological Know-How
• Latest Products and Services
• M&A and Partnerships
• Marketing Tactics
• Organization and Management
Table of Contents
1. Executive Summary
2. Competitive Landscape Overview
3. Alnylam Pharmaceuticals
4. Amgen
5. Biogen
6. BioNTech
7. CSL Behring
8. Genmab
9. Gilead Sciences
10. Moderna
11. Regeneron
12. Vertex Pharmaceuticals
13. Comparative Analysis
14. Appendix
List of Tables
Table 1. Global Biotechnology Market Share by the World's Leading Companies 2025
Table 2. World's Leading Biotechnology Companies — Revenue Comparison 2023–2025
Table 3. World's Leading Biotechnology Companies — R&D Investment 2023–2025
Table 4. World's Leading Biotechnology Companies — M&A Activity 2023–2025
Table 5. Alnylam Pharmaceuticals — Key Financial Metrics 2023–2025
Table 6. Amgen — Key Financial Metrics 2023–2025
Table 7. Biogen — Key Financial Metrics 2023–2025
Table 8. BioNTech — Key Financial Metrics 2023–2025
Table 9. CSL Behring — Key Financial Metrics 2023–2025
Table 10. Genmab — Key Financial Metrics 2023–2025
Table 11. Gilead Sciences — Key Financial Metrics 2023–2025
Table 12. Moderna — Key Financial Metrics 2023–2025
Table 13. Regeneron — Key Financial Metrics 2023–2025
Table 14. Vertex Pharmaceuticals — Key Financial Metrics 2023–2025
Table 15. SWOT Analysis Summary — World's Leading Biotechnology Companies
Table 16. Technology Capability Assessment — World's Leading Biotechnology Companies
Table 17. Geographic Revenue Distribution — World's Leading Biotechnology Companies 2025
Companies Profiled
Alnylam Pharmaceuticals
Amgen
Biogen
BioNTech
CSL Behring
Genmab
Gilead Sciences
Moderna
Regeneron
Vertex Pharmaceuticals
